Fine needle aspiration cytology of thyroid lesions: A single-centre experience

  • Dr. Sheema Sheikh Associate Professor, Department of Pathology, GMC, Srinagar, Jammu & Kashmir, India
  • Dr. Farhat Abbas Senior Resident, Department of Pathology, GMC, Srinagar, Jammu & Kashmir, India
  • Dr. Ambreen Beigh Medical officer, Department of pathology, GMC, Srinagar, Jammu & Kashmir, India
  • Dr. Summiya Farooq Assistant Professor, Department of pathology, GMC, Srinagar, Jammu & Kashmir, India
  • Dr. Muzamil Latief Senior Resident, Department of Nephrology, GMC, Srinagar, India
Keywords: FNAC, Thyroid, Bethesda system, Cytology

Abstract

Background FNAC (Fine needle aspiration cytology) is an easy and cost-effective method for the diagnosis of thyroid lesions. The use of the Bethesda system is largely helpful in eliciting the risk of malignancy and helps in further management of patients with thyroid lesions. In this study we studied thyroid lesions and reported them according to the BETHESDA System of Classification based on cytological features on FNAC.

Materials and Methods: In this prospective single-centre study conducted over 2 years we included 642 patients with thyroid lesions who underwent FNAC. These lesions were then classified according to the Bethesda system based on cytomorphological features.

Results: Out of 642 patients included in our study, 100 were males and 542 were females with a male: female ratio of 1:5.42. The age of the patient population in our study ranged from 4-94 years. Among 642 cases in our study most (61.38%) cases were benign whereas 9.96% cases were found to be malignant and 2.60% cases were suspicious of malignancy.

Conclusion: Bethesda System of reporting FNAC of thyroid lesions is a standardized system and helps in deciding diagnostic approach and appropriate management of patients.

Downloads

Download data is not yet available.

References

Cooper DS, Doherty GM, Haugen BR, et al. American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19(11):1167–214.

Tan GH, Gharib H. Thyroid incidentalomas: management approaches to nonpalpable nodules discovered incidentally on thyroid imaging. Ann Intern Med. 1997 Feb 1;126(3):226-31. doi: 10.7326/0003-4819-126-3-199702010-00009.

Roman SA. Endocrine tumors: evaluation of the thyroid nodule. Curr Opin Oncol. 2003 Jan;15(1):66-70. doi: 10.1097/00001622-200301000-00010.

Levine RA. Current guidelines for the management of thyroid nodules. Endocr Pract.2012 Jul-Aug;18(4):596-9. doi:10.4158/EP12071.CO.

Gharib H, Papini E, Paschke R, Duick DS, Valcavi R, Hegedüs L, Vitti P. AACE/AME/ETA Task Force on Thyroid Nodules. American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and EuropeanThyroid Association Medical Guidelines for Clinical Practice for the Diagnosis and Management of Thyroid Nodules. Endocr Pract. 2010 May-Jun;16 Suppl 1:1-43. doi: 10.4158/10024.GL.

Moon WJ, Baek JH, Jung SL, Kim DW, Kim EK, Kim JY, Kwak JY, Lee JH, Lee JH, Lee YH, Na DG, Park JS, Park SW; Korean Society of Thyroid Radiology (KSThR); Korean Society of Radiology. Ultrasonography and the ultrasound-based management of thyroid nodules: consensus statement and recommendations. Korean J Radiol. 2011 Jan-Feb;12(1):1-14. doi: 10.3348/kjr.2011.12.1.1. Epub 2011 Jan 3.

Polyzos SA, Kita M, Avramidis A. Thyroid nodules - stepwise diagnosis and management. Hormones (Athens). 2007 Apr-Jun;6(2):101-19. doi: 10.14310/horm.2002.111107.

Wong CK, Wheeler MH. Thyroid nodules: rational management. World J Surg. 2000 Aug;24(8):934-41. doi: 10.1007/s002680010175.

Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, 1998. CA Cancer J Clin. 1998 Jan-Feb;48(1):6-29. doi: 10.3322/canjclin.48.1.6. Erratum in: CA Cancer J Clin 1998 May-Jun;48(3):192. Erratum in: CA Cancer J Clin 1998 Nov-Dec;48(6):329.

Cibas ES, Ali SZ. The Bethesda System for Reporting Thyroid Cytopathology. Thyroid. 2009 Nov;19(11):1159-65. doi: 10.1089/thy.2009.0274.

VanderLaan PA, Marqusee E, Krane JF. Features associated with locoregional spread of papillary carcinoma correlate with diagnostic category in the Bethesda System for reporting thyroid cytopathology. Cancer Cytopathol. 2012 Aug 25;120(4):245-53. doi: 10.1002/cncy.21189. Epub 2012 Mar 20.

Kleiman DA, Beninato T, Soni A, Shou Y, Zarnegar R, Fahey TJ 3rd. Does bethesda category predict aggressive features in malignant thyroid nodules? Ann Surg Oncol. 2013 Oct;20(11):3484-90. doi: 10.1245/s10434-013-3076-5. Epub 2013 Jun 28.

Yassa L, Cibas ES, Benson CB, Frates MC, Doubilet PM, Gawande AA, Moore FD Jr, Kim BW, Nosé V, Marqusee E, Larsen PR, Alexander EK. Long-term assessment of a multidisciplinary approach to thyroid nodule diagnostic evaluation. Cancer. 2007 Dec 25;111(6):508-16. doi: 10.1002/cncr.23116.

Rabaglia JL, Kabbani W, Wallace L, Holt S, Watumull L, Pruitt J, Snyder WH, Nwariaku FE. Effect of the Bethesda system for reporting thyroid cytopathology on thyroidectomy rates and malignancy risk in cytologically indeterminate lesions. Surgery. 2010 Dec;148(6):1267-72; discussion 1272-3. doi: 10.1016/j.surg.2010.09.017.

Hirsch D, Robenshtok E, Bachar G, Braslavsky D, Benbassat C. The Implementation of the Bethesda System for Reporting Thyroid Cytopathology Improves Malignancy Detection Despite Lower Rate of Thyroidectomy in Indeterminate Nodules. World J Surg. 2015 Aug;39(8):1959-65. doi: 10.1007/s00268-015-3032-6.

Yoon JH, Lee HS, Kim EK, Moon HJ, Kwak JY. Thyroid Nodules: Nondiagnostic Cytologic Results according to Thyroid Imaging Reporting and Data System before and after Application of the Bethesda System. Radiology. 2015 Aug;276(2):579-87. doi: 10.1148/radiol.15142308. Epub 2015 Apr 3.

Srbova L, Gabalec F, Ryska A, Cap J. Results of retrospective classification of thyroid FNAs according to the Bethesda system: would this have improved accuracy? Cytopathology. 2015 Aug;26(4):231-7. doi: 10.1111/cyt.12171. Epub 2014 Jul 30.

Sullivan PS, Hirschowitz SL, Fung PC, Apple SK. The impact of atypia/follicular lesion of undetermined significance and repeat fine-needle aspiration: 5 years before and after implementation of the Bethesda System. Cancer Cytopathol. 2014 Dec;122(12):866-72. doi: 10.1002/cncy.21468. Epub 2014 Jul 30.

Ugurluoglu C, Dobur F, Karabagli P, Celik ZE. Fine needle aspiration biopsy of thyroid nodules: cytologic and histopathologic correlation of 1096 patients. Int J Clin Exp Pathol. 2015 Nov 1;8(11):14800-5.

Bhagat DV, Tailor DH, Kaptan DK, et al. Diagnostic role of the Bethesda system for reporting thyroid lesions: Effective tool for managing thyroid lesions. Global J of Medical Research (C). 2014;14 (1):12-8.

Garg S, Desai NJ, Mehta D, Vaishnav M. To Establish Bethesda System for Diagnosis of Thyroid Nodules on the Basis of Fnac with Histopathological Correlation. J Clin Diagn Res. 2015 Dec;9(12):EC17-21. doi: 10.7860/JCDR/2015/14823.6897. Epub 2015 Dec 1.

Kulkarni DC, Mittal DM, Nema DM, et al. Diagnostic role of the Bethesda system for reporting thyroid cytopathology in an academic institute of central India: One year experience. Indian Journal of Basic and Applied Medical Research 2016;5: 157-66.

Sawarkar PR, Mahore SD, Bothale KA, et al. Cytological evaluation of thyroid lesions based on the Bethesda system. IOSR-JDMS 2016;15: 112-7.

Kumar D, Dwivedi G, Bhargava S. The Bethesda system for reporting thyroid cytopathology. Journal of medical science and clinical research.2014;2(12):3171-6.

Yang J, Schnadig V, Logrono R, Wasserman PG. Fine-needle aspiration of thyroid nodules: a study of 4703 patients with histologic and clinical correlations. Cancer. 2007 Oct 25;111(5):306-15. doi: 10.1002/cncr.22955.

Bagga PK, Mahajan NC. Fine needle aspiration cytology of thyroid swellings: how useful and accurate is it? Indian J Cancer. 2010 Oct-Dec;47(4):437-42. doi: 10.4103/0019-509X.73564.

Harvey AM, Mody DR, Amrikachi M. Thyroid fine-needle aspiration reporting rates and outcomes before and after Bethesda implementation within a combined academic and community hospital system. Arch Pathol Lab Med. 2013 Nov;137(11):1664-8. doi: 10.5858/arpa.2012-0366-OA.

Patel MM, Patel K, Kaptan KR, et al. Fine needle aspiration cytology as a first line investigation in thyroid Lesions. National Journal of Medical Research 2013;3(02):106-10.

Park JH, Yoon SO, Son EJ, Kim HM, Nahm JH, Hong S. Incidence and malignancy rates of diagnoses in the bethesda system for reporting thyroid aspiration cytology: an institutional experience. Korean J Pathol. 2014 Apr;48(2):133-9. doi: 10.4132/KoreanJPathol.2014.48.2.133. Epub 2014 Apr 28.

Naz S, Hashmi AA, Khurshid A, Faridi N, Edhi MM, Kamal A, Khan M. Diagnostic accuracy of Bethesda system for reporting thyroid cytopathology: an institutional perspective. Int Arch Med. 2014 Oct 31;7:46. doi: 10.1186/1755-7682-7-46..

Bolland MJ, Eagleton C, Orr-Walker B. Diagnostic category agreement and malignancy rates in clinician-categorised, non-standardised thyroid cytology reports. N Z Med J. 2014 Dec 19;127(1407):49-55.

Arul P, Masilamani S. A correlative study of solitary thyroid nodules using the bethesda system for reporting thyroid cytopathology. J Cancer Res Ther. 2015 Jul-Sep;11(3):617-22. doi: 10.4103/0973-1482.157302.

Vasudha MB, Hemali JT, Kumar BRK. Diagnostic role of Bethesda system of reporting thyroid lesions. Global journals Inc.(US). Global journal of medical research: Microbiology and pathology volume 2014;14(1): 57.87554.

Prathima S, Suresh TN, Kumar MH, et al. Impact of the Bethesda system in reporting thyroid cytopathology. Thyroid fresearch and practice.2016;13(1):9

Sinna EA, Ezzat N. Diagnostic accuracy of fine needle aspiration cytology in thyroid lesions. J Egypt Natl Canc Inst. 2012 Jun;24(2):63-70. doi: 10.1016/j.jnci.2012.01.001. Epub 2012 Feb 25.

Mondal SK, Sinha S, Basak B, Roy DN, Sinha SK. The Bethesda system for reporting thyroid fine needle aspirates: A cytologic study with histologic follow-up. J Cytol. 2013 Apr;30(2):94-9. doi: 10.4103/0970-9371.112650.

Agrawal D, Bhake AS, Rastogi N, et al. Role of Bethesda system for reporting thyroid lesion and its correlation with histopathological diagnosis.Journal of Datta Meghe Institute of Medical Sciences university(DU).2019;14(2):74-81

Lakshmi S, Latha B, Nirmala C. Spectrum Of Thyroid Lesions On Fine Needle Aspiration Cytology. Journal Of International Medicine And Dentistry.2015;2(1):53-62

Soni S, Deepika Gupta D, Bordia S, et al. Categorization of thyroid lesions FNAC in Bethesda system: An institutional study in southern Rajasthan. International Journal of Clinical and Diagnostic Pathology. 2020; 3(2): 159-164. DOI: 10.33545/pathol.2020.v3.i2c.246

Nandedkar SS, Dixit M, Malukani K, Varma AV, Gambhir S. Evaluation of Thyroid Lesions by Fine-needle Aspiration Cytology According to Bethesda System and its Histopathological Correlation. Int J Appl Basic Med Res. 2018 Apr-Jun;8(2):76-82. doi: 10.4103/ijabmr.IJABMR_169_17.

Mehra P, Verma AK. Thyroid cytopathology reporting by the bethesda system: a two-year prospective study in an academic institution. Patholog Res Int. 2015;2015:240505. doi: 10.1155/2015/240505. Epub 2015 Jan 22.

How to Cite
Dr. Sheema Sheikh, Dr. Farhat Abbas, Dr. Ambreen Beigh, Dr. Summiya Farooq, & Dr. Muzamil Latief. (2021). Fine needle aspiration cytology of thyroid lesions: A single-centre experience. Tropical Journal of Pathology and Microbiology, 7(2), 85-92. Retrieved from https://pathology.medresearch.in/index.php/jopm/article/view/524
Section
Original Article